There have been case reports where patients taking GLP-1 receptor agonists had gastric residue despite following standard fasting protocols, though the overall frequency of this complication is not well established
doi: 10.1017/S002966510700585X 257
3 Consumers inspired to manage their health through diet and exercise alone are adopting GLP-1-inspired eating patterns focused on portion control, fiber and protein intake and metabolic health without pharmaceutical intervention
It reduced weight by an average of 18.1% and also reduced OSA sleep disruptions by up to 63%
This broadens the component profile into additional peptide-signaling, barrier-function, and cellular-response research categories
Caution urged as drugs shift from treatment to trend Locally, the growing off-label use and aggressive marketing of GLP-1 medications for quick or cosmetic weight loss particularly among individuals who are neither diabetic nor clinically obese has alarmed medical practitioners